OUR TECHNOLOGY

EBRT or External Beam Radiation Therapy uses machines known as linear accelerators to beam radiation which delivers dosage deep onto the area of the body where the cancer is located. The use of EBRT machines has significantly reduced side effects and modern state-of-the-art equipment has vastly improved the ability to deliver radiation. EBRT is usually given for approximately 6 to 8 weeks on an outpatient basis.

3D-CRT or Three-Dimensional Conformal Radiation Therapy is a method for delivering EBRT more precisely by using a special CT scan and computerized model. 3D-CRT promises to reduce the damage to tissues near the cancer. 3D-CRT is being tested to determine if higher doses can be given safely with higher outcomes.

IMRT or Intensity Modulated Radiation Therapy allows radiation oncologists to customize dose varying the amount of radiation given to different parts of the area being treated. It is an advanced form of 3-D conformal radiation therapy. Computer-controlled moveable “leaves” adjust the radiation intensity so that more radiation can be delivered to the tumor while normal cells nearby receive less.

IGRT of Image-Guided Radiation Therapy involves imaging during the course of treatment allowing more accurate delivery of radiation. Images taken during the planning phase of treatment are compared to images taken during treatment. Sometimes the location of the cancer may shift in a patient’s body and this treatment allows better accuracy of the radiation delivery. IGRT is often used along with EBRT, 3D-CRT or IMRT.

Brachytherapy is internal radiation, sometimes referred to as “seeds” or “implants.” In brachytherapy, radioactive material is placed directly into or near the cancer. Brachytherapy may be used alone or along with external beam radiation therapy. The seeds or implants may be permanent or temporary. Brachytherapy has been effective in the treatment of several types of cancer such as prostate, cervix, uterus, vagina, head and neck and breast.

Women with breast cancer who choose breast conservation rather than a mastectomy may benefit from Breast Brachytherapy. After the removal of the tumor in a process called a lumpectomy, radiation may be administered using traditional EBRT which typically takes 5 to 6 weeks of treatment. Sometimes it is possible to reduce this treatment time down to as little as 2 to 3 days by using breast brachytherapy. Because of its short duration, women who do not wish to undergo 6 to 8 weeks of EBRT in breast conservation treatment find this an attractive option.

SRS or Stereotactic Radiosurgery is delivered on an outpatient basis and delivers a high dose of radiation to a highly defined target. It is a non-invasive procedure used for the treatment of brain tumors, arteriovenous malformation, and other conditions.

Optune is intended as a treatment for adult patients (22 years of age or older) with histologically-confirmed glioblastoma multiforme (GBM). Optune with temozolomide is indicated for the treatment of adult patients with newly diagnosed, supratentorial glioblastoma following maximal debulking surgery, and completion of radiation therapy together with concomitant standard of care chemotherapy.

Optune Lua is approved for the first-line treatment of adult patients with unresectable, locally advanced or metastatic, MPM to be used concurrently with pemetrexed and platinum-based chemotherapy. In a clinical study, MPM patients treated with Optune Lua plus chemotherapy experienced a median overall survival of 18.2 months.

SpaceOAR Hydrogel is clinically shown to minimize urinary, sexual, bowel side effects and protect quality of life for prostate cancer patients undergoing radiation therapy.